Biocon And Viatris Get CRL From FDA On Insulin Aspart

Biosimilar Rival To NovoLog Already Approved In Europe As Kixelle

Sign outside of FDA's headquarters in White Oak, MD
The FDA has issued a CRL over the proposed NovoLog rival • Source: Alamy

More from Biosimilars

More from Products